Sign in
4

Changes in Ownership

DEXCOM INC Filed Acc 0001093557-23-000245

Director sold 2,000 shares at $122.77 ($245,548)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ALTMAN STEVEN R Director 2023-12-15 Sale 10b5-1 −2,000 $122.77 $245,548 54,700 I: show line 1 in the form
Open-market sales · 2,000 sh · avg $122.77 · $245,548
Loading xslF345X05/edgardoc.xml…